Drug for Alzheimer’s disease does not appear to slow cognitive decline (Science Daily)
Monday, December 28th, 2009Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo, ... continue reading